The company said it agreed to sell a series of 6 Notes, ranging from the March 19, 2024 April 15, 2027 due 4.600% Notes to the April 15, 2064 due 5.500% Notes.

1. 01

   The company said it agreed to sell a series of 6 Notes, ranging from the March 19, 2024 April 15, 2027 due 4.600% Notes to the April 15, 2064 due 5.500% Notes.

2. 02

   UnitedHealth Group disclosed the aggregate principal amount of the Notes as 4.600% Series $500,000,000, 4.700% $400,000,000, 4.900% $1,000,000,000, 5.000% $1,250,000,000, 5.375% $1,750,000,000 and 5.500% $1,100,000,000.

3. 03

   The company said it agreed to sell the Notes under its Underwriting Agreement and Pricing Agreement dated March 19, 2024, with BofA Securities, Barclays Capital, J.P. Morgan Securities and Mizuho Securities USA as representative underwriters, and that the Notes were issued on March 21, 2024.

4. 04

   The company said the Notes were registered under the Securities Act of 1933 through its automatic shelf registration statement on Form S-3, File No. 333-270279. It said it will file issuance documents, including the Underwriting Agreement and Pricing Agreement, as exhibits.

Analysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.